SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000920465-15-000073
Filing Date
2015-09-30
Accepted
2015-09-30 17:05:56
Documents
10
Effectiveness Date
2015-09-30

Document Format Files

Seq Description Document Type Size
1 S-8 s-8sep302015.htm S-8 123365
2 EXHIBIT 5.1 exhibit51opinionofgibsondu.htm EX-5.1 8346
3 EXHIBIT 23.1 exhibit231smconsent.htm EX-23.1 7613
4 EXHIBIT 99.2 exhibit992mulroyoption.htm EX-99.2 61105
5 g13417g01n88.jpg GRAPHIC 10661
6 g13417g18r47.jpg GRAPHIC 9106
7 g13417g46j65.jpg GRAPHIC 7119
8 ljpcpressrelease_image1a01.jpg GRAPHIC 21134
9 smlogobottom.jpg GRAPHIC 7559
10 smlogotop.jpg GRAPHIC 6590
  Complete submission text file 0000920465-15-000073.txt   287294
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-207212 | Film No.: 151134482
SIC: 2836 Biological Products, (No Diagnostic Substances)